1-11 of 11
Jun Zhao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

Open Access
Chong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia, Jianying Zhou, Dong-Wan Kim, Ross Andrew Soo, Ying Cheng, Shun Lu, Sang Won Shin, James Chih-Hsin Yang, Yiping Zhang, Jun Zhao, Karin Berghoff, Rolf Bruns, Andreas Johne, Yi-Long Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (10): 1879–1886.
https://doi.org/10.1158/1078-0432.CCR-22-3318
Published: 15 May 2023
View articletitled, Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis
Open the PDF for Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis in another window
Includes: Supplementary data
Journal Articles

Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection

Free
Michael Chiorazzi, Erin Silva, Kristina Brower, Patrick Wong, Carolina Lucas, Jon Klein, Feimei Liu, Maura Nakahata, Jun Zhao, Nur-Taz Rahman, Camila Odio, Santos Bermejo, Shelli F. Farhadian, Charles Dela Cruz, Arnau Casanovas-Massana, John Fournier, Catherine Muenker, Anne L. Wyllie, Chantal B.F. Vogels, Chaney C. Kalinich, Mary E. Petrone, Isabel M. Ott, Anne E. Watkins, Adam J. Moore, Tara Alpert, Yuval Kluger, Aaron Ring, Nathan D. Grubaugh, Akiko Iwasaki, Albert I. Ko, Roy S. Herbst
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6_Supplement): S03-03.
https://doi.org/10.1158/1557-3265.COVID-19-21-S03-03
Published: 15 March 2021
View articletitled, Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection
Journal Articles

Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy

Available to Purchase
Caicun Zhou, Yina Wang, Jun Zhao, Gongyan Chen, Zhihua Liu, Kangsheng Gu, Meijuan Huang, Jianxing He, Jianhua Chen, Zhiyong Ma, Jifeng Feng, Jianhua Shi, Xinmin Yu, Ying Cheng, Yu Yao, Yuan Chen, Renhua Guo, Xiaoyan Lin, Zhehai Wang, Guanghui Gao, Quanren Wang, Weixia Li, Xinfeng Yang, Lihong Wu, Jun Zhang, Shengxiang Ren
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (5): 1296–1304.
https://doi.org/10.1158/1078-0432.CCR-20-3136
Published: 01 March 2021
View articletitled, Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy
Open the PDF for Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract PR14: Sub-nucleosomal fragmentation in urine cell-free DNA

Free
Havell Markus, Jun Zhao, Tania Contente-Cuomo, Elizabeth Raupach, Ahuva Odenheimer-Bergman, Sydney Connor, Bradon McDonald, Elizabeth Hutchins, Marissa McGilvrey, Michelina C. de la Maza, Kendall Van Keuren-Jensen Van Jensen, Patrick Pirrotte Pirrotte, Ajay Goel, Carlos Becerra, Daniel D. Von Hoff, Scott Celinski, Pooja Hingorani, Muhammed Murtaza
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): PR14.
https://doi.org/10.1158/1557-3265.LiqBiop20-PR14
Published: 01 June 2020
View articletitled, Abstract PR14: Sub-nucleosomal fragmentation in urine cell-free DNA
Journal Articles

The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma

Available to Purchase
Minglei Zhuo, Yanfang Guan, Xue Yang, Lingzhi Hong, Yuqi Wang, Zhongwu Li, Runzhe Chen, Hussein A. Abbas, Lianpeng Chang, Yuhua Gong, Nan Wu, Jia Zhong, Wenting Chen, Hanxiao Chen, Zhi Dong, Xiang Zhu, Jianjie Li, Yuyan Wang, Tongtong An, Meina Wu, Ziping Wang, Jiayin Wang, Emily B. Roarty, Waree Rinsurongkawong, Jeff Lewis, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, John V. Heymach, Ignacio I. Wistuba, Neda Kalhor, Ling Yang, Xin Yi, P. Andrew Futreal, Bonnie S. Glisson, Xuefeng Xia, Jianjun Zhang, Jun Zhao
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (4): 892–901.
https://doi.org/10.1158/1078-0432.CCR-19-0556
Published: 14 February 2020
View articletitled, The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma
Open the PDF for The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma in another window
Includes: Supplementary data
Journal Articles

Genetic Polymorphisms Predisposing the Interleukin 6–Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations

Free
Wenbin Liu, Jianfeng Wu, Fan Yang, Longteng Ma, Chong Ni, Xiaomei Hou, Ling Wang, Aijing Xu, Jiahui Song, Yang Deng, Linfeng Xian, Zixiong Li, Shuo Wang, Xi Chen, Jianhua Yin, Xue Han, Chengzhong Li, Jun Zhao, Guangwen Cao
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5525–5536.
https://doi.org/10.1158/1078-0432.CCR-18-3083
Published: 13 September 2019
View articletitled, Genetic Polymorphisms Predisposing the Interleukin 6–Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations
Open the PDF for Genetic Polymorphisms Predisposing the Interleukin 6–Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations in another window
Includes: Supplementary data
Journal Articles

Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells

Free
Zhe Su, Zhijie Wang, Xiaohui Ni, Jianchun Duan, Yan Gao, Minglei Zhuo, Ruoyan Li, Jun Zhao, Qi Ma, Hua Bai, Hengyu Chen, Shuhang Wang, Xixi Chen, Tongtong An, Yuyan Wang, Yanhua Tian, Jiangyong Yu, Di Wang, Xiaoliang Sunney Xie, Fan Bai, Jie Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 5049–5060.
https://doi.org/10.1158/1078-0432.CCR-18-3571
Published: 15 August 2019
View articletitled, Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
Open the PDF for Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells in another window
Includes: Supplementary data
Journal Articles

Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression

Free
Vincent Bernard, Alexander Semaan, Jonathan Huang, F. Anthony San Lucas, Feven C. Mulu, Bret M. Stephens, Paola A. Guerrero, Yanqing Huang, Jun Zhao, Nabiollah Kamyabi, Subrata Sen, Paul A. Scheet, Cullen M. Taniguchi, Michael P. Kim, Ching-Wei Tzeng, Matthew H. Katz, Aatur D. Singhi, Anirban Maitra, Hector A. Alvarez
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (7): 2194–2205.
https://doi.org/10.1158/1078-0432.CCR-18-1955
Published: 01 April 2019
View articletitled, Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
Open the PDF for Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression in another window
Includes: Supplementary data
Journal Articles

Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer

Free
Jiangyong Yu, Shuhang Wang, Wei Zhao, Jianchun Duan, Zhijie Wang, Hanxiao Chen, Yanhua Tian, Di Wang, Jun Zhao, Tongtong An, Hua Bai, Meina Wu, Jie Wang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (9): 2148–2158.
https://doi.org/10.1158/1078-0432.CCR-17-1932
Published: 30 April 2018
View articletitled, Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer
Open the PDF for Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Free
Jun Zhao, Mark Z. Ma, Hening Ren, Zhenqiu Liu, Martin J. Edelman, Hong Pan, Li Mao
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3567–3576.
https://doi.org/10.1158/1078-0432.CCR-12-3478
Published: 30 June 2013
View articletitled, Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy
Open the PDF for Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non–Small Cell Lung Cancer

Free
Shuhang Wang, Tongtong An, Jie Wang, Jun Zhao, Zhijie Wang, Minglei Zhuo, Hua Bai, Lu Yang, Yan Zhang, Xin Wang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, Meina Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (4): 1324–1330.
https://doi.org/10.1158/1078-0432.CCR-09-2672
Published: 15 February 2010
View articletitled, Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non–Small Cell Lung Cancer
Open the PDF for Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non–Small Cell Lung Cancer in another window